title: The evaluation and treatment of prostate-related LUTS in the primary care setting: the next STEP.
abstract: The primary care provider is in an optimal position to identify and care for the patient affected by prostate-related lower urinary tract symptoms (BPH-LUTS). This assessment can be readily accomplished with a good history and only a few simple, in-office tests. In some instances, the primary care provider may believe that they do not have the experience, comfort level or time to perform an adequate evaluation of the problem. Therefore, in this article, we describe the function of the lower urinary tract, as well as the rationale behind the medical history, examination and tests needed in order to diagnose and treat, or refer, the patient presenting with BPH-LUTS. We will also update the literature-based STEP (simplified treatment of the enlarged prostate) approach, which was initially published in 2009, to include recently described therapeutic options.
authors.affiliation: , 214 N. West Ave, Jackson, Michigan, 49201, USA, matttoren@yahoo.com.
authors.forename: Matt T
authors.initials: MT
authors.lastname: Rosenberg
authors.forename: David
authors.initials: D
authors.lastname: Staskin
authors.forename: John
authors.initials: J
authors.lastname: Riley
authors.forename: Grannum
authors.initials: G
authors.lastname: Sant
authors.forename: Martin
authors.initials: M
authors.lastname: Miner
mesh_terms: D058891:5-alpha Reductase Inhibitors / Q000627:therapeutic use; D058668:Adrenergic alpha-1 Receptor Antagonists / Q000627:therapeutic use; D058667:Adrenergic beta-3 Receptor Agonists / Q000627:therapeutic use; D006801:Humans; D059411:Lower Urinary Tract Symptoms / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D008297:Male; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use; D011320:Primary Health Care / Q000379:methods*; D011470:Prostatic Hyperplasia / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D012017:Referral and Consultation
chemical_list: D058891:5-alpha Reductase Inhibitors; D058668:Adrenergic alpha-1 Receptor Antagonists; D058667:Adrenergic beta-3 Receptor Agonists; D018727:Muscarinic Antagonists; D058986:Phosphodiesterase 5 Inhibitors
references.citation: Eur Urol. 2000 Apr;37(4):413-20
references.pmid: 10765071
references.citation: J Urol. 2003 Aug;170(2 Pt 1):530-47
references.pmid: 12853821
references.citation: Can J Urol. 2012 Oct;19 Suppl 1:28-35
references.pmid: 23089345
references.citation: Mayo Clin Proc. 2012 Aug;87(8):766-78
references.pmid: 22862865
references.citation: Cleve Clin J Med. 2007 May;74 Suppl 3:S15-20
references.pmid: 17546829
references.citation: Clin Ther. 2007 Jan;29(1):17-25
references.pmid: 17379044
references.citation: Eur Urol. 2007 Jun;51(6):1717-23
references.pmid: 17258855
references.citation: J Cataract Refract Surg. 2005 Apr;31(4):664-73
references.pmid: 15899440
references.citation: Urology. 2004 Dec;64(6):1144-8
references.pmid: 15596187
references.citation: Int J Clin Pract. 2010 Mar;64(4):488-96
references.pmid: 20039975
references.citation: Eur Urol. 2012 May;61(5):917-25
references.pmid: 22297243
references.citation: Eur Urol. 2010 Jan;57(1):123-31
references.pmid: 19825505
references.citation: J Urol. 1992 Nov;148(5):1549-57; discussion 1564
references.pmid: 1279218
references.citation: N Engl J Med. 2003 Jul 17;349(3):215-24
references.pmid: 12824459
references.citation: Rev Urol. 2012;14(3-4):79-86
references.pmid: 23526698
references.citation: Can J Urol. 2008 Aug;15 Suppl 1:78-91; discussion 91
references.pmid: 18700069
references.citation: Urology. 2004 Dec;64(6):1081-8
references.pmid: 15596173
references.citation: Eur Urol. 2008 Jun;53(6):1236-44
references.pmid: 18281145
references.citation: J Sex Med. 2008 Sep;5(9):2170-8
references.pmid: 18638006
references.citation: N Engl J Med. 2009 Mar 26;360(13):1310-9
references.pmid: 19297565
references.citation: J Urol. 2004 Oct;172(4 Pt 1):1399-403
references.pmid: 15371854
references.citation: J Clin Endocrinol Metab. 1996 Feb;81(2):814-9
references.pmid: 8636309
references.citation: Int J Clin Pract. 2013 Feb;67(2):114-9
references.pmid: 23305473
references.citation: J Urol. 2005 Dec;174(6):2273-5. discussion 2275-6
references.pmid: 16280803
references.citation: Rev Urol. 2009 Summer;11(3):127-33
references.pmid: 19918338
references.citation: J Urol. 2011 May;185(5):1793-803
references.pmid: 21420124
references.citation: Int J Clin Pract. 2007 Sep;61(9):1535-46
references.pmid: 17627768
references.citation: J Sex Med. 2012 Jun;9(6):1624-33
references.pmid: 22510238
references.citation: Can J Urol. 2012 Oct;19 Suppl 1:10-7
references.pmid: 23089343
references.citation: Fam Med. 1997 May;29(5):321-5
references.pmid: 9165283
references.citation: J Urol. 2006 Apr;175(4):1422-6; discussion 1426-7
references.pmid: 16516013
references.citation: Eur Urol. 2004 Nov;46(5):547-54
references.pmid: 15474261
references.citation: J Sex Med. 2006 Jul;3(4):662-667
references.pmid: 16839322
references.citation: BJU Int. 2005 Mar;95(4):549-53
references.pmid: 15705078
references.citation: Eur Urol. 2013 Jul;64(1):118-40
references.pmid: 23541338
references.citation: N Engl J Med. 2010 Apr 1;362(13):1192-202
references.pmid: 20357281
references.citation: BJU Int. 2004 May;93(7):985-90
references.pmid: 15142148
references.citation: Eur Urol. 2006 Apr;49(4):740-5
references.pmid: 16460876
references.citation: Urology. 2006 Jun;67(6):1199-204
references.pmid: 16765179
references.citation: Int J Clin Pract. 2011 Sep;65(9):989-96
references.pmid: 21733048
references.citation: J Urol. 2007 Mar;177(3):1071-7
references.pmid: 17296414
references.citation: J Urol. 2008 Oct;180(4):1228-34
references.pmid: 18722631
references.citation: JAMA. 2006 Nov 15;296(19):2319-28
references.pmid: 17105794
references.citation: Eur Urol. 2003 Oct;44(4):461-6
references.pmid: 14499682
references.citation: J Urol. 2005 Apr;173(4):1256-61
references.pmid: 15758764
references.citation: J Urol. 2008 Jul;180(1):47-54
references.pmid: 18485378
references.citation: Scand J Urol Nephrol. 2009;43(4):307-14
references.pmid: 19396723
references.citation: Int J Clin Pract. 2011 Oct;65(10):1026-36
references.pmid: 21923844
references.citation: J Urol. 2004 Nov;172(5 Pt 1):1935-40
references.pmid: 15540759
references.citation: Neurourol Urodyn. 2002;21(2):167-78
references.pmid: 11857671
references.citation: Int J Clin Pract. 2008 Jul;62(7):1076-86
references.pmid: 18479366
references.citation: BJU Int. 2011 Aug;108(3):388-94
references.pmid: 21631695
references.citation: Curr Urol Rep. 2009 Jul;10(4):254-60
references.pmid: 19570485